The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Meningococcal Infections Vaccine Market Research Report 2025
Synopsis
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.
The global Meningococcal Infections Vaccine market was valued at US$ 488.2 million in 2023 and is anticipated to reach US$ 679.8 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Infections Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Infections Vaccine.
Report Scope
The Meningococcal Infections Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Infections Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Infections Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Segment by Type
Bivalent
Quadrivalent
Segment by Application
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Infections Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.
The global Meningococcal Infections Vaccine market was valued at US$ 488.2 million in 2023 and is anticipated to reach US$ 679.8 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Infections Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Infections Vaccine.
Report Scope
The Meningococcal Infections Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Infections Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Infections Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Segment by Type
Bivalent
Quadrivalent
Segment by Application
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Infections Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bivalent
1.2.3 Quadrivalent
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Group A Meningococcal Bacterial Infections
1.3.3 Group C Meningococcal Bacterial Infectio
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2019-2030)
2.2 Meningococcal Infections Vaccine Growth Trends by Region
2.2.1 Global Meningococcal Infections Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Meningococcal Infections Vaccine Market Dynamics
2.3.1 Meningococcal Infections Vaccine Industry Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2019-2024)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2023
3.5 Meningococcal Infections Vaccine Key Players Head office and Area Served
3.6 Key Players Meningococcal Infections Vaccine Product Solution and Service
3.7 Date of Enter into Meningococcal Infections Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2025-2030)
5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2019-2030)
6.2 North America Meningococcal Infections Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Meningococcal Infections Vaccine Market Size by Country (2019-2024)
6.4 North America Meningococcal Infections Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2019-2030)
7.2 Europe Meningococcal Infections Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Meningococcal Infections Vaccine Market Size by Country (2019-2024)
7.4 Europe Meningococcal Infections Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2019-2030)
9.2 Latin America Meningococcal Infections Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Meningococcal Infections Vaccine Market Size by Country (2019-2024)
9.4 Latin America Meningococcal Infections Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Meningococcal Infections Vaccine Introduction
11.1.4 Pfizer Revenue in Meningococcal Infections Vaccine Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Sinopharm
11.2.1 Sinopharm Company Detail
11.2.2 Sinopharm Business Overview
11.2.3 Sinopharm Meningococcal Infections Vaccine Introduction
11.2.4 Sinopharm Revenue in Meningococcal Infections Vaccine Business (2019-2024)
11.2.5 Sinopharm Recent Development
11.3 CanSino Biologics
11.3.1 CanSino Biologics Company Detail
11.3.2 CanSino Biologics Business Overview
11.3.3 CanSino Biologics Meningococcal Infections Vaccine Introduction
11.3.4 CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2019-2024)
11.3.5 CanSino Biologics Recent Development
11.4 Zhi Fei Biological
11.4.1 Zhi Fei Biological Company Detail
11.4.2 Zhi Fei Biological Business Overview
11.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Introduction
11.4.4 Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2019-2024)
11.4.5 Zhi Fei Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bivalent
Table 3. Key Players of Quadrivalent
Table 4. Global Meningococcal Infections Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Meningococcal Infections Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Meningococcal Infections Vaccine Market Share by Region (2019-2024)
Table 8. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Meningococcal Infections Vaccine Market Share by Region (2025-2030)
Table 10. Meningococcal Infections Vaccine Market Trends
Table 11. Meningococcal Infections Vaccine Market Drivers
Table 12. Meningococcal Infections Vaccine Market Challenges
Table 13. Meningococcal Infections Vaccine Market Restraints
Table 14. Global Meningococcal Infections Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Meningococcal Infections Vaccine Market Share by Players (2019-2024)
Table 16. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2023)
Table 17. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Meningococcal Infections Vaccine Product Solution and Service
Table 21. Date of Enter into Meningococcal Infections Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2019-2024)
Table 25. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2025-2030)
Table 27. Global Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2019-2024)
Table 29. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2025-2030)
Table 31. North America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Meningococcal Infections Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Meningococcal Infections Vaccine Product
Table 49. Pfizer Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Sinopharm Company Detail
Table 52. Sinopharm Business Overview
Table 53. Sinopharm Meningococcal Infections Vaccine Product
Table 54. Sinopharm Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)
Table 55. Sinopharm Recent Development
Table 56. CanSino Biologics Company Detail
Table 57. CanSino Biologics Business Overview
Table 58. CanSino Biologics Meningococcal Infections Vaccine Product
Table 59. CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)
Table 60. CanSino Biologics Recent Development
Table 61. Zhi Fei Biological Company Detail
Table 62. Zhi Fei Biological Business Overview
Table 63. Zhi Fei Biological Meningococcal Infections Vaccine Product
Table 64. Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)
Table 65. Zhi Fei Biological Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Infections Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Meningococcal Infections Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Bivalent Features
Figure 4. Quadrivalent Features
Figure 5. Global Meningococcal Infections Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Meningococcal Infections Vaccine Market Share by Application: 2023 VS 2030
Figure 7. Group A Meningococcal Bacterial Infections Case Studies
Figure 8. Group C Meningococcal Bacterial Infectio Case Studies
Figure 9. Meningococcal Infections Vaccine Report Years Considered
Figure 10. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Meningococcal Infections Vaccine Market Share by Region: 2023 VS 2030
Figure 13. Global Meningococcal Infections Vaccine Market Share by Players in 2023
Figure 14. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2023
Figure 16. North America Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Meningococcal Infections Vaccine Market Share by Country (2019-2030)
Figure 18. United States Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Meningococcal Infections Vaccine Market Share by Country (2019-2030)
Figure 22. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Meningococcal Infections Vaccine Market Share by Region (2019-2030)
Figure 30. China Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Meningococcal Infections Vaccine Market Share by Country (2019-2030)
Figure 38. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Meningococcal Infections Vaccine Market Share by Country (2019-2030)
Figure 42. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)
Figure 45. Sinopharm Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)
Figure 46. CanSino Biologics Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)
Figure 47. Zhi Fei Biological Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
